Gallo O, Sardi I, Pepe G, Franchi A, Attanasio M, Giusti B, Bocciolini C, Abbate R
Institute of Otolaryngology Head and Neck Surgery, University of Florence, Italy.
Int J Cancer. 1999 Jul 19;82(2):180-6. doi: 10.1002/(sici)1097-0215(19990719)82:2<180::aid-ijc5>3.0.co;2-p.
Head-and-neck cancer (HNC) patients have a high risk of developing second primary tumors of the upper aerodigestive tract, the main cause of death. Although the roles of tobacco and diet in multiple head-and-neck carcinogenesis have been thoroughly investigated, little is known about individual genetic susceptibility factors involved in this process. Genomic instability, reflecting the propensity and the susceptibility of the genome to acquire multiple alterations, could be considered a driving force behind multiple carcinogenesis. Mutation of the p53 tumor-suppressor gene has been proposed to play an important role in this process. Therefore, we evaluated the incidence of inherited p53 germ-line alteration(s) in a population of 24 consecutive HNC patients and their first-degree relatives affected by multiple malignancies as well as the occurrence of p53 somatic acquired mutation(s) in 16 cancers, including first and second primaries from 5 HNCs of the same group. Mutations in exons 4-11 of the p53 gene were investigated using SSCP-PCR analysis and DNA sequencing. Analysis was extended to the peripheral blood and cancer biopsies available from first-degree relatives of cancer-prone families with p53 germ-line mutations. p53 germ-line mutations were identified in the peripheral blood and corresponding cancers of 3 HNC patients who had multiple malignancies. The only missense mutation detected was mapped in exon 6; it is a GTG to GAG substitution with an amino acid change from Val to Glu at codon 197. The remaining 2 p53 germ-line mutations were single-nucleotide substitutions without amino acid change in exon 6 (codon 213, CGA to CGG) and in exon 8 (codon 295, CCT to CCC), respectively. These mutations were found in HNC patients with a family history of cancer. Abnormal expression of wild-type p53 protein in normal and pathological tissues from patients with the same sense single-nucleotide substitutions was detected by immuno-histochemistry.
头颈癌(HNC)患者发生上呼吸道消化道第二原发性肿瘤的风险很高,这是主要死因。尽管烟草和饮食在多重头颈癌发生中的作用已得到充分研究,但对于该过程中涉及的个体遗传易感性因素却知之甚少。基因组不稳定性反映了基因组获得多种改变的倾向和易感性,可被视为多重致癌作用背后的驱动力。有人提出p53肿瘤抑制基因突变在这一过程中起重要作用。因此,我们评估了24例连续的HNC患者及其受多种恶性肿瘤影响的一级亲属中遗传性p53种系改变的发生率,以及16例癌症中p53体细胞获得性突变的发生情况,包括同一组5例HNC患者的第一原发性和第二原发性肿瘤。使用SSCP-PCR分析和DNA测序研究p53基因第4至11外显子的突变。分析扩展到有p53种系突变的癌症易患家族一级亲属的外周血和癌组织活检样本。在3例患有多种恶性肿瘤的HNC患者的外周血和相应癌症中鉴定出p53种系突变。检测到的唯一错义突变位于第6外显子;它是一个从GTG到GAG的替换,密码子197处的氨基酸从Val变为Glu。其余2个p53种系突变分别是第6外显子(密码子213,CGA到CGG)和第8外显子(密码子295,CCT到CCC)的单核苷酸替换,无氨基酸变化。这些突变见于有癌症家族史的HNC患者。通过免疫组织化学检测了具有相同意义单核苷酸替换的患者正常和病理组织中野生型p53蛋白的异常表达。